These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8928846)

  • 1. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia.
    Mak RH
    Am J Physiol; 1996 May; 270(5 Pt 2):F839-44. PubMed ID: 8928846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia.
    Mak RH
    J Pediatr; 1996 Jul; 129(1):97-104. PubMed ID: 8757568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of erythropoietin in patients on peritoneal dialysis.
    Mak RH
    Pediatr Nephrol; 1998 Oct; 12(8):660-5. PubMed ID: 9811391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of erythropoietin on glucose tolerance in hemodialysis patients.
    Chagnac A; Weinstein T; Zevin D; Korzets A; Hirsh J; Gafter U; Levi J
    Clin Nephrol; 1994 Dec; 42(6):398-400. PubMed ID: 7882604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients.
    Biolo G; Guarnieri G; Barazzoni R; Panzetta G
    Clin Exp Med; 2011 Sep; 11(3):181-7. PubMed ID: 21076998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretion and growth failure in uremia.
    Mak RH
    Pediatr Res; 1995 Sep; 38(3):379-83. PubMed ID: 7494663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of body iron stores on the serum erythropoietin concentration in hemodialyzed patients.
    Teruel JL; Marcen R; Navarro JF; Villafruela JJ; Fernandez Lucas M; Rivera M; Ortuño J
    Am J Nephrol; 1994; 14(2):95-8. PubMed ID: 8080013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
    Aljama P; Ward MK; Pierides AM; Eastham EJ; Ellis HA; Feest TG; Conceicao S; Kerr DN
    Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients.
    Spaia S; Pangalos M; Askepidis N; Pazarloglou M; Mavropoulou E; Theodoridis S; Dimitrakopoulos K; Milionis A; Vayonas G
    Nephron; 2000 Apr; 84(4):320-5. PubMed ID: 10754408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia.
    Hu JP; Cheng X; Xu XF; Yu GJ; Luo F; Zhang GS; Yang N; Shen P; Yan XY
    J Biol Regul Homeost Agents; 2016; 30(2):535-40. PubMed ID: 27358145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients.
    Canavese C; Bergamo D; Ciccone G; Longo F; Fop F; Thea A; Martina G; Piga A
    Kidney Int; 2004 Mar; 65(3):1091-8. PubMed ID: 14871430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B; Guastaferro P; Gironda A; Marano V; Morrongiello L; Cillo N; Zito B; Nigro F; Frieri A; Rubino R; Bellizzi V
    G Ital Nefrol; 2002; 19(5):552-9. PubMed ID: 12439845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
    Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
    Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral iron absorption in hemodialysis patients treated with erythropoietin.
    Donnelly SM; Posen GA; Ali MA
    Clin Invest Med; 1991 Aug; 14(4):271-6. PubMed ID: 1782724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deferoxamine therapy on insulin resistance in end-stage renal disease patients with iron overload.
    Alnahal AA; Tahan M; Fathy A; Fathy T
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):808-13. PubMed ID: 24969192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.